XRF Scientific Ltd Posts Record FY26 Revenue as Adjusted PBT Rises 10%

XRF Scientific delivered a record FY26 full-year result with revenue up 8% to $64.4m and adjusted profit before tax rising 10% to $16.1m, capped by a record June quarter and a fully franked final dividend of 4.5 cents per share.
By Josua Ferreira -
  • XRF Scientific posted record FY26 revenue of $64.4m, up 8%, with adjusted profit before tax rising 10% to $16.1m — all three divisions contributed to the result.
  • The June 2026 quarter was itself a record, delivering $17.2m in revenue and $4.7m in adjusted PBT, driven by strong Orbis crusher and consumable sales alongside international growth.
  • The Board declared a final fully franked dividend of 4.5 cents per share at a 61% payout ratio, with a DRP available at a 2.5% discount.
  • The CGA acquisition — purchased for USD $4m from existing cash — is expected to begin contributing instrument sales revenue in 1H27, adding a third growth product line alongside Orbis and xrTGA.
  • Consumable sales have started strongly in early FY27 driven by international orders, and management has flagged at least six new machines under development as part of its FY27 growth roadmap.
Summarise with AI:

XRF Scientific delivers record FY26 result with revenue up 8% to $64.4m

XRF Scientific reported a record full-year result for FY26, the year ended June 2026, with revenue climbing 8% to $64.4m from $59.5m the prior year. Adjusted Profit Before Tax rose 10% to $16.1m from $14.6m, while Statutory Profit Before Tax lifted 5% to $15.4m.

The Board declared a final fully franked dividend of 4.5 cents per share. The result reflected broad-based growth across the group, underpinned by strong mining and industrial demand alongside continued international expansion.

The adjusted figure excludes $0.69m in acquisition costs and setup and startup costs associated with two new international offices for FY26.

FY26 headline results at a glance

The table below summarises the group’s full-year and June quarter (Q4 FY26) performance.

Metric FY26 FY25 Change Q4 FY26
Revenue $64.4m $59.5m +8% $17.2m
Adjusted PBT $16.1m $14.6m +10% $4.7m
Statutory PBT $15.4m $14.6m +5% –
Operating cash inflow $11.4m – – –

Record June quarter caps the year

The June 2026 quarter marked a record result, with revenue of $17.2m and adjusted profit before tax of $4.7m. The company attributed the strong finish to robust consumable and Orbis crusher sales, along with continued growth in international sales.

Divisional performance drove the result

Each of the group’s three divisions contributed to the record outcome, with Capital Equipment and Precious Metals cited as the main drivers.

XRF Scientific FY26 Divisional Performance Breakdown

Capital Equipment — record $5.3m PBT

The Capital Equipment division delivered a record profit before tax of $5.3m from revenue of $26.3m. Orbis was a strong contributor, with revenue up 26% to $8.9m, while xrTGA sales reached $1m for the first time, which the company expects to grow into a material contributor for the division.

The manufacturing and engineering handover for the CGA acquisition is progressing well, with instrument sales expected to commence in 1H27 as planned. The division is positioned for growth in FY27 through Orbis, xrTGA and the new CGA product line.

The CGA acquisition was completed for USD $4m in cash from existing reserves, with the Bruker Combustion Gas Analysis business generating USD $5.3m in unaudited 2025 revenue across instruments, spare parts and servicing before transferring production to XRF’s Perth factory.

Precious Metals — record $4.5m PBT

The Precious Metals division recorded revenue of $24.6m and a record profit before tax of $4.5m. Demand for recycling platinum products continued strongly throughout the year.

Higher platinum prices reduced demand for new products in Q2 and Q3, though the company noted a notable improvement in demand since Q4.

Consumables — stronger second half

The Consumables division generated profit before tax of $6.8m from revenue of $18.1m. Following a pickup in international sales, the second half was considerably stronger, with PBT of $3.8m achieved versus $3.0m in the first half.

Demand from the mining sector was robust, with Asia continuing as a key growth market. Consumable sales have started strongly in FY27, driven by orders from international customers.

The India office expansion, announced in early 2026, transitioned XRF from a seven-year distributor relationship to direct operations, positioning the group to capture improved margins and a multi-year upgrade cycle as the market shifts from pressed pellet to lithium borate fusion methods.

What XRF Scientific does — and why it matters

XRF Scientific manufactures equipment and chemicals used to prepare and analyse the composition and purity of materials. Its technology supports industrial quality control and process control across sectors including metals and mining, construction materials, chemicals and petrochemicals.

The company serves a blue-chip customer base that includes BHP Billiton, Rio Tinto, Vale, Glencore, Bureau Veritas and ALS. It operates manufacturing, sales and support facilities across Perth, Melbourne, Europe, the USA, Canada and India, supported by a global network of distributors.

Dividend and capital allocation

The Board declared a final fully franked dividend, with the following details:

  • Final fully franked dividend of 4.5 cents per share

  • Payout ratio of 61% of net profit after tax

  • Dividend reinvestment plan (DRP) available via Automic Group with a 2.5% discount

The dividend was maintained at the same payout ratio as last year, allowing the company to retain cash for what management described as numerous growth opportunities.

Growth outlook for FY27

Management outlined a strategic roadmap centred on the following growth drivers:

  1. Three newer product lines — Orbis, xrTGA and CGA — each capable of making material contributions to future growth

  2. CGA instrument sales expected to commence in 1H27

  3. At least six new machines under development

  4. Continued international expansion via the new international offices

  5. Ongoing review of complementary acquisition opportunities

Management commentary

Managing Director Vance Stazzonelli commented on the full-year result and the record June quarter.

Vance Stazzonelli, Managing Director

“During the year we saw strong demand from our mining and industrial customers, with international sales continuing to grow. International sales growth remains a key focus, which is expected to accelerate through initiatives such as the new international offices and CGA acquisition. The Precious Metals and Capital Equipment divisions both performed strongly and were the main contributors to the increased results. The June 2026 quarter was a record result with revenue of $17.2m and adjusted profit before tax of $4.7m.”

The record FY26 outcome leaves the group carrying momentum into FY27, supported by its newer product lines, an expanding international footprint and a pipeline of new machines under development.

Don’t Miss the Next Industrial Sector Winner

Get FREE breaking ASX news delivered to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ subscribers already staying ahead of the market with Big News Blast. Click the “Free Alerts” button to receive real-time coverage the moment market-moving announcements hit the ASX.


Frequently Asked Questions

What did XRF Scientific report for its FY26 full-year result?

XRF Scientific reported record FY26 revenue of $64.4m, up 8% from $59.5m, with adjusted profit before tax rising 10% to $16.1m. The Board declared a final fully franked dividend of 4.5 cents per share.

What is XRF Scientific and what does it do?

XRF Scientific manufactures equipment and chemicals used to prepare and analyse the composition and purity of materials, serving sectors including metals and mining, construction, chemicals and petrochemicals. Its customers include BHP, Rio Tinto, Vale and Glencore.

What is the XRF Scientific dividend for FY26?

XRF Scientific declared a final fully franked dividend of 4.5 cents per share for FY26, representing a payout ratio of 61% of net profit after tax, with a dividend reinvestment plan available at a 2.5% discount.

What is driving XRF Scientific's growth in FY27?

XRF Scientific's FY27 growth is expected to be driven by three newer product lines — Orbis, xrTGA and CGA — with CGA instrument sales commencing in 1H27, at least six new machines under development, and continued international expansion including new offices and the transition to direct operations in India.

What was the CGA acquisition and how much did XRF Scientific pay?

XRF Scientific acquired the Bruker Combustion Gas Analysis business for USD $4m in cash from existing reserves. The business generated USD $5.3m in unaudited 2025 revenue across instruments, spare parts and servicing, with production now being transferred to XRF's Perth factory.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher